Modeling Parkinson’s disease in midbrain-like organoids

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Lisa M. Smits - , University of Luxembourg (Autor:in)
  • Lydia Reinhardt - , Technische Universität Dresden, Max Planck Institute for Molecular Biomedicine (Autor:in)
  • Peter Reinhardt - , Technische Universität Dresden, Max Planck Institute for Molecular Biomedicine, AbbVie (Autor:in)
  • Michael Glatza - , Technische Universität Dresden, Max Planck Institute for Molecular Biomedicine (Autor:in)
  • Anna S. Monzel - , University of Luxembourg (Autor:in)
  • Nancy Stanslowsky - , Leibniz Universität Hannover (LUH) (Autor:in)
  • Marcelo D. Rosato-Siri - , EURAC Research (Autor:in)
  • Alessandra Zanon - , EURAC Research (Autor:in)
  • Paul M. Antony - , University of Luxembourg (Autor:in)
  • Jessica Bellmann - , Technische Universität Dresden (Autor:in)
  • Sarah M. Nicklas - , University of Luxembourg (Autor:in)
  • Kathrin Hemmer - , University of Luxembourg (Autor:in)
  • Xiaobing Qing - , University of Luxembourg (Autor:in)
  • Emanuel Berger - , University of Luxembourg (Autor:in)
  • Norman Kalmbach - , Leibniz Universität Hannover (LUH) (Autor:in)
  • Marc Ehrlich - , Max Planck Institute for Molecular Biomedicine (Autor:in)
  • Silvia Bolognin - , University of Luxembourg (Autor:in)
  • Andrew A. Hicks - , EURAC Research (Autor:in)
  • Florian Wegner - , Leibniz Universität Hannover (LUH) (Autor:in)
  • Jared L. Sterneckert - , IPS Zellen und neurodegenerative Erkrankungen (NFoG) (Autor:in)
  • Jens C. Schwamborn - , University of Luxembourg (Autor:in)

Abstract

Modeling Parkinson’s disease (PD) using advanced experimental in vitro models is a powerful tool to study disease mechanisms and to elucidate unexplored aspects of this neurodegenerative disorder. Here, we demonstrate that three-dimensional (3D) differentiation of expandable midbrain floor plate neural progenitor cells (mfNPCs) leads to organoids that resemble key features of the human midbrain. These organoids are composed of midbrain dopaminergic neurons (mDANs), which produce and secrete dopamine. Midbrain-specific organoids derived from PD patients carrying the LRRK2-G2019S mutation recapitulate disease-relevant phenotypes. Automated high-content image analysis shows a decrease in the number and complexity of mDANs in LRRK2-G2019S compared to control organoids. The floor plate marker FOXA2, required for mDAN generation, increases in PD patient-derived midbrain organoids, suggesting a neurodevelopmental defect in mDANs expressing LRRK2-G2019S. Thus, we provide a robust method to reproducibly generate 3D human midbrain organoids containing mDANs to investigate PD-relevant patho-mechanisms.

Details

OriginalspracheEnglisch
Aufsatznummer5
FachzeitschriftNPJ Parkinson's disease
Jahrgang5
Ausgabenummer1
PublikationsstatusVeröffentlicht - 1 Dez. 2019
Peer-Review-StatusJa

Externe IDs

ORCID /0000-0002-7688-3124/work/142250026